RxDoctor Payments Data

Ronald Dose, MD

Family Medicine · Amana, IANPI 1891763389

Payments from drug & device makers

$468in general payments, 2019–2025

Across 24 payments — averaging $19.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$174
  • Sanofi Pasteur Inc.$58
  • Merck$50
  • Corium, LLC$43
  • Biohaven Pharmaceutical Holding Company Ltd.$35
  • Collegium Pharmaceutical, Inc.$33
  • plus $75 from 4 others

What the payments were for

  • Food & beverage$468100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$468 in reported general payments places this provider in the 70th percentile of 1,357 family medicine providers in Iowa.

See all family medicine providers in Iowa

Medicare billing

Part B allowed, 2024
$98,150
Medicare patients
266
Services billed
1,521

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban133$43,589
OzempicSemaglutide14$22,676
XareltoRivaroxaban54$22,329
JardianceEmpagliflozin32$13,970
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr11$12,178
Trelegy ElliptaFluticasone/Umeclidin/Vilanter16$10,255
MyrbetriqMirabegron27$6,474
Potassium Chloride140$6,351
NuedextaDextromethorphan Hbr/Quinidine13$4,839
Cyclosporine21$4,069
Memantine Hcl137$4,048
Pregabalin102$3,951
GemtesaVibegron13$3,149
Levothyroxine Sodium265$2,925
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen94$2,733

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$174$43,589133 claims
Novo NordiskOzempic$14$22,67614 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 1,357 family medicine providers in Iowa.

Other family medicine in Amana

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →